| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 16, 2022
TCT 2022: Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets Medtronic today announced findings from its Pathological Study of Hypo-Attenuated...
-
Jul 11, 2022
A minimally invasive approach, the ILLUMISITE™ platform navigates accurately to even the most distant areas of the lung, and can sample multi-directionally for a thorough biopsy. Medtronic...
-
May 31, 2022
Medtronic presence to include 1 3 data presentations, a LinkedIn Livestream featuring Que Dallara, EVP & President, Medtronic Diabetes, comprehensive exhibit booth with presentations and a product theatre
-
May 27, 2022
Built on the market-leading IN.PACT™ Admiral™ DCB technology, the IN.PACT™ 018 DCB is engineered to cross tight lesions and designed for better deliverability§
-
May 17, 2022
Mid-term results of Optimize PRO clinical study reinforces benefits of predictability and control using cusp overlap technique
-
May 2, 2022
EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population
-
Apr 28, 2022
Heart Rhythm 2022: Sub-analysis indicates patients with intermittent monitoring may not be optimally managed for secondary stroke prevention
-
Apr 27, 2022
Medtronic, the global leader in medical technology, today announced new randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug coated balloon (DCB)...
-
Apr 25, 2022
Medtronic plc, the global leader in medical technology, today announced its participation at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking...
